Announcement on Summary of 2026 Restricted Share Incentive Plan (Draft)
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Summary of 2026 Restricted Share Incentive Plan (Draft)
Filed with SSE · · 21 pages · Chinese
Summary by 6ix AI
The plan aims to enhance corporate governance and retain key employees by offering restricted shares to selected personnel. The plan outlines the conditions for granting and vesting these shares, including performance assessments and compliance with legal requirements.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Release
Hangzhou Biotest Biotech Co., Ltd. on 6ix
Earlier from Hangzhou Biotest Biotech
- Announcement on Implementation Results of Share Repurchase
- Announcement on Progress in Repurchasing 1% Shares through Call Auction
- Announcement on Adjusting Upper Limit of Share Repurchase Price after Implementation of Dividend Distribution for 2025
- Announcement on Initially Repurchasing Shares through Call Auction and Progress in Shares Repurchase
- Announcement on Implementation of Dividend Distribution for 2025
Later from Hangzhou Biotest Biotech
- Review Opinion and Statement on the Public Disclosure of the List of Participants under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
- Announcement on Resolutions of the 9th Meeting of the 4th Board of Directors
- (688767)"HANGZHOU BIOTEST BIOTECH CO., LTD."Announcement on Convening the Q3 2026 Performance Briefing
- (688767)"HANGZHOU BIOTEST BIOTECH CO., LTD."Announcement on Resolutions of the 10th Meeting of the 4th Board of Directors
- (688767)"HANGZHOU BIOTEST BIOTECH CO., LTD."Report for Q3 2026
Follow Hangzhou Biotest Biotech into a list and get an email when it puts out news.
Follow Hangzhou Biotest Biotech